Hans Moebius is Chief Medical Officer at Athira Pharma, Inc. (ATHA). They have made 2 open-market trades across 1 company since 2022, most recently 2024-01-04.
CIK 0001822494
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $45K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATHA | 91,482 | $618K |
Shares reported on the most recent Form 4, priced at the 2024-01-08 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.